Brainomix 360 e-CTA vs Google Med-PaLM 2

Brainomix 360 e-CTA is designed for seamless integration into existing clinical workflows, delivering results to PACS, mobile apps, email, or web UI within minutes. It also offers a mobile app for quick, secure access to AI-powered scan results, enabling physicians to view high-resolution scans and coordinate care from any device. Google Med-PaLM 2, while powerful, is currently available to a limited number of Google Cloud customers and requires approval for medical use cases, suggesting a more restricted and potentially less immediate integration pathway for general users.

Brainomix 360 e-CTA has demonstrated significant real-world clinical impact, including a 100% increase in endovascular thrombectomy rates and a reduction in door-in-door-out times by over an hour in stroke care. It provides automated collateral assessment, LVO detection, and integrates with other stroke imaging modules for comprehensive decision support. While Google Med-PaLM 2 shows expert-level performance on medical licensing exams and strong capabilities in medical Q&A and reasoning, its real-world clinical deployment and impact are still in earlier stages of evaluation and adoption.

Both tools require contacting the vendor for pricing, indicating a lack of public transparency. Brainomix offers flexible licensing for individual modules or packages, which could provide value based on specific hospital needs. Google Med-PaLM 2 is available through Google's MedLM API and select partnerships, with access requiring approval, which might imply a more complex and potentially higher barrier to entry for some organizations.

Brainomix 360 e-CTA is designed for enterprise deployment, offering both cloud and on-site server options, and integrates with existing hospital networks, PACS, and enterprise directories like LDAP and Microsoft AD. It also supports single sign-on and multi-factor authentication, with patient data pseudonymized and encrypted. Google Med-PaLM 2 is cloud-based and available through Google Cloud Vertex AI, but its current limited access and requirement for approval for medical use cases suggest it is still in a more controlled rollout phase for enterprise adoption.

Google Med-PaLM 2 represents a significant innovation as a large language model specifically fine-tuned for healthcare, demonstrating expert-level performance on medical licensing exams and developing multimodal capabilities to interpret various medical data, including images. Brainomix 360 e-CTA is innovative in its automated and standardized assessment of stroke imaging, but Med-PaLM 2's broader application of generative AI and multimodal reasoning across diverse medical tasks positions it as a more fundamentally innovative technology in the AI healthcare space.

Brainomix provides readily accessible support resources including FAQs, user manuals, and direct contact information on their website. This indicates a structured approach to supporting their users with clear documentation. While Google offers extensive documentation for its cloud services, specific support and documentation details for Med-PaLM 2 beyond its research papers and API access information are less explicitly highlighted for general users.